OurCrowd portfolio company ReWalk, developer of the FDA approved ReWalk exoskeleton device, was featured on Bloomberg Television’s “Taking Stock.” In the interview, ReWalk Robotics CEO Larry Jasinksi speaks with Pimm Fox about how the company’s robotic system is helping people walk again.

ReWalk raised $1,320,000 from OurCrowd investors in June 2013.

View the video below or play it on Bloomberg TV here.